Business Insights, Sep 2007, Pages: 182
culture
Transgenics/plant systems
Conclusions and key findings
Chapter 2 Manufacturing of biologics
Summary
Introduction
The biopharmaceutical process
The Upstream Process
Cell banking and seed
Elsevier Science and Technology, June 2011, Pages: 6000
defines the dynamic and multi-displinary nature of biotechnology research, applications, and tools
- Revision of one of the most highly praised comprehensives of our time
- Edited by an international
Informa Healthcare, Jan 2006, Pages: 234
Manufacturing provides an in-depth understanding of the biopharmaceutical industry. It consists of 10 chapters and highlights the production technologies and operations that occur in the manufacturing facility
CanBiotech, Aug 2003, Pages: 27
research providing animal model development, animal model maintenance, animal model testing, and discovery information services.
Transgenic Production Systems-Opportunities for Protein Manufacturing discusses how
Frost & Sullivan, Nov 2006, Pages: 123
: Bioluminescence is the use of transgenic mouse models that carry a fluorophore that can be tracked under an imaging system. Fluorescence imaging is the use of fluorescent markers transplanted into cells
Espicom Business Intelligence Ltd, July 2007, Pages: 306
techniques that combine new-generation imaging agents and advanced imaging tools to capture specific molecular pathways in the body, particularly disease targets.
The clinical benefits of MI are clear
